𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and immunogenicity of a candidate parvovirus B19 vaccine

✍ Scribed by David I. Bernstein; Hana M. El. Sahly; Wendy A. Keitel; Mark Wolff; Gina Simone; Claire Segawa; Susan Wong; Daniel Shelly; Neal S. Young; Walla Dempsey

Book ID
116964101
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
733 KB
Volume
29
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Immunogenicity and safety of an experime
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients
✍ Frederik Nevens; Jane N. Zuckerman; Andrew K. Burroughs; Maria-Christina Jung; J πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

Patients with chronic liver disease are at higher risk of hepatitis B (HB) virus infection before and after liver transplantation, and they commonly have a suboptimal immune response to HB vaccines. In this randomized trial, we compared the immunogenicity of primary vaccination with 2 doses of an ex